Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Sarcomas
  •  Melanoma/Skin Cancer
  •  Urological Cancers
  •  Neoadjuvant Therapy
  •  Cervical Cancer
  •  Colon Cancer
  •  Radiological Techniques and Scans
  •  Adjuvant Therapy


Citation: Clin Oncol. 2021;6(1):1829.DOI: 10.25107/2474-1663.1829

Delivered Dose Verification for Lung Cancer Stereotactic Body Radiotherapy Using Cone-Beam CT

Liu Xi, Hu Chang, Liu Zhongqiang, Zhu Zongda and Deng Zhenxiang

Guangdong Pharmaceutical University, China
The Second Affiliated Hospital of Hainan Medical University, China
School of Biomedical Engineering, Southern Medical University, China
Department of Radiation Oncology, Xiang'an Hospital of Xiamen University, China

*Correspondance to: Deng Zhenxiang 

 PDF  Full Text Research Article | Open Access


Purpose: Verified the delivered dose distribution of lung cancer Stereotactic Body Radiotherapy (SBRT) using the cone-beam CT images.
Methods: Five lung cancer patients underwent SBRT with 25 CBCT images were enrolled in this study. Delivered dose distributions were recalculated on CBCT images with deformed and nondeformed method, respectively. The planned and delivered dose distributions were compared using the dose-volume histograms.
Results: The delivered target coverage (V100) per patient inside target volume deviated on average were 0.83% ± 0.86% and 1.38% ±1.40% for Pct vs. Pcbct and Pct vs. Pdcbct, respectively. The Conformity Index (CI) and Gradient Index (GI) showed a good agreement among the plans. For the critical organs, only minor differences were observed between the planned dose and delivered dose.


Lung Cancer; Stereotactic body radiotherapy; Cone beam CT; Dose verification

Cite the Article:

Xi L, Chang H, Zhongqiang L, Zongda Z, Zhenxiang D. Delivered Dose Verification for Lung Cancer Stereotactic Body Radiotherapy Using Cone-Beam CT. Clin Oncol. 2021;6:1829..

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Erlotinib Treatment Beyond Progression in EGFR Mutant Patients Who Have Responded to EGFR TKIs in Stage IIIB/IV NSCLC: An Open Label Randomized Trial
 Abstract  PDF  Full Text
Bioinformatics-Based Identification of CCNB2 as a Key Gene in the Progression of Chromophobe Cell Carcinoma of Kidney
 Abstract  PDF  Full Text
View More...